Hyperpolarization Modulation of the T‐Type hCa <sub>v</sub> 3.2 Channel by Human Synenkephalin [1–53], a Shrew Neurotoxin Analogue without Paralytic Effects

R Ryo Fukuoka (Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan) Y Yusuke Yano (Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan) N Nozomi Hara (Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan) C Chihiro Sadamoto (Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan) A Andres D. Maturana (Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan) M Masaki Kita

Abstract

Abstract Mammalian secreted venoms mainly consist of peptides and proteases used for defense or predation. Blarina paralytic peptides (BPPs), mealworm‐targeting neurotoxins from shrew, are very similar to human synenkephalin. This peptide is released from proenkephalin in the brain along with opioid peptides that mediate analgesic and antidepressant effects, though its physiological function is unclear. Here, we synthesized and characterized human synenkephalin [1–53] (hSYN) and reveal its disulfide bond connectivity. Similar to BPP2, hSYN caused a hyperpolarizing shift in the human T‐type voltage‐gated calcium channel (hCa v 3.2) at 0.74 µM, but did not paralyze mealworms. Molecular docking and molecular dynamics simulations showed that hSYN and BPP2 interact with hCa v 3.2 channel differently, due to differences in polar residues. Since Ca v 3.2 channel regulates neuronal excitability and is implicated in conditions like autism and epilepsy, our findings on hSYN could provide insight into the channel gating and agonistic mechanisms, along with potential pathways for developing treatments for neurological disorders.

Article Details

Volume / Issue Vol. 64, Issue 27
Published July 01, 2025
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (6)

R

Ryo Fukuoka

Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan

Y

Yusuke Yano

Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan

N

Nozomi Hara

Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan

C

Chihiro Sadamoto

Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan

A

Andres D. Maturana

Department of Applied Biosciences, Graduate School of Bioagricultural Sciences Nagoya University Furo‐cho, Chikusa Nagoya 464–8601 Japan

M

Masaki Kita